Facebook
Twitter
LinkedIn
Forward2021 Recorded Consultant Pharmacist Update- Medication Management for the Older Adult - DOACs in Special Populations: Chronic Liver Disease & Cancer-Associated VTE
2021- Recorded CE Program Packet -Taylor Steuber.pdf
Explores the role of DOACs in unique populations including chronic liver disease and cancer-associated thrombosis. These are unique clinical situations where there is emerging evidence to expand the role of DOACs in anticoagulation management.
Target Audience
This knowledge-based program is intended for pharmacists.
Learning Objectives
- Discuss the role of direct oral anticoagulants in patients with chronic liver disease or cancer-associated venous thromboembolism
- Review consensus recommendations for direct oral anticoagulants in patients with chronic liver disease or cancer-associated venous thromboembolism
- Design effective and safe treatment regimens for patients with chronic liver disease with atrial fibrillation or venous thromboembolism or patients with cancer-associated venous thromboembolism
Auburn University is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education; credits are recognized nationwide. The Universal Activity Number for this knowledge-based program is 0001-0000-21-018-H01-P and is intended for pharmacists. The initial release date for this home-study program is September 16, 2021 and the intended expiration date is September 16, 2024.
Available Credit
- 1.00 ACPE PharmacyAuburn University is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education; credits are recognized nationwide.